Literature DB >> 34509066

Cerebrovascular reactivity is blunted in young adults with major depressive disorder: The influence of current depressive symptomology.

Ashley M Darling1, Rauchelle E Richey2, John D Akins1, Erika F H Saunders3, R Matthew Brothers1, Jody L Greaney4.   

Abstract

BACKGROUND: In middle-aged adults with depression, cerebral vasodilatory reactivity is blunted; however, this has not been examined in treatment-naïve young adults with major depressive disorder (MDD). We tested the hypothesis that cerebrovascular reactivity would be blunted in young adults (18-30 yrs) with MDD compared to healthy non-depressed adults (HA) and would be attenuated to a greater extent in adults with symptomatic MDD (sMDD) compared to adults with MDD in remission (euthymic MDD; eMDD).
METHODS: Sixteen adults with MDD [21±3yrs; n = 8 sMDD (6 women); n = 8 eMDD (5 women)] and 14 HA (22±3yrs; 9 women) participated. End-tidal carbon dioxide concentration (PETCO2; capnograph), beat-to-beat mean arterial pressure (MAP; finger photoplethysmography), middle cerebral artery blood velocity (MCAv; transcranial Doppler ultrasound), and internal carotid artery (ICA) diameter and blood velocity (Doppler ultrasound) were continuously measured during baseline and rebreathing-induced hypercapnia. Cerebrovascular reactivity was calculated as the relative increase in vascular conductance during hypercapnia.
RESULTS: In adults with MDD, cerebrovascular reactivity in the MCA (∆39±9 HA vs. ∆31±13% MDD, p = 0.04), but not the ICA (∆36±24 HA vs. ∆34±18% MDD, p = 0.84), was blunted compared to HA. In the MCA, cerebrovascular reactivity was reduced in adults with sMDD compared to adults with eMDD (∆36±11 eMDD vs. ∆25±13% sMDD, p = 0.02). LIMITATIONS: The cross-sectional nature approach limits conclusions regarding the temporal nature of this link.
CONCLUSION: These data indicate that MCA cerebrovascular reactivity is blunted in young adults with MDD and further modulated by current depressive symptomology, suggesting that the management of depressive symptomology may secondarily improve cerebrovascular health.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Cerebral blood flow; Depression; Middle cerebral artery velocity; Transcranial Doppler ultrasound; vasomotor reactivity

Mesh:

Substances:

Year:  2021        PMID: 34509066      PMCID: PMC8667006          DOI: 10.1016/j.jad.2021.08.061

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  57 in total

1.  Abnormal brachial artery flow-mediated vasodilation in young adults with major depression.

Authors:  S Rajagopalan; R Brook; M Rubenfire; E Pitt; E Young; B Pitt
Journal:  Am J Cardiol       Date:  2001-07-15       Impact factor: 2.778

2.  Norming plans for the NIH Toolbox.

Authors:  Jennifer L Beaumont; Richard Havlik; Karon F Cook; Ron D Hays; Kathleen Wallner-Allen; Samuel P Korper; Jin-Shei Lai; Christine Nord; Nicholas Zill; Seung Choi; Kathleen J Yost; Vitali Ustsinovich; Pim Brouwers; Howard J Hoffman; Richard Gershon
Journal:  Neurology       Date:  2013-03-12       Impact factor: 9.910

3.  Oxidative Stress Contributes to Microvascular Endothelial Dysfunction in Men and Women With Major Depressive Disorder.

Authors:  Jody L Greaney; Erika F H Saunders; Lakshmi Santhanam; Lacy M Alexander
Journal:  Circ Res       Date:  2019-02-15       Impact factor: 17.367

4.  Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion.

Authors:  H Markus; M Cullinane
Journal:  Brain       Date:  2001-03       Impact factor: 13.501

Review 5.  Cerebrovascular hemodynamics in Alzheimer's disease and vascular dementia: a meta-analysis of transcranial Doppler studies.

Authors:  Behnam Sabayan; Steffy Jansen; Anna M Oleksik; Matthias J P van Osch; Mark A van Buchem; Peter van Vliet; Anton J M de Craen; Rudi G J Westendorp
Journal:  Ageing Res Rev       Date:  2011-12-27       Impact factor: 10.895

6.  Establishing a common metric for depressive symptoms: linking the BDI-II, CES-D, and PHQ-9 to PROMIS depression.

Authors:  Seung W Choi; Benjamin Schalet; Karon F Cook; David Cella
Journal:  Psychol Assess       Date:  2014-02-17

Review 7.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

8.  Cerebrovascular reactivity over time-course - from major depressive episode to remission.

Authors:  Harald Lemke; Ana Gómez-Carrillo de Castro; Peter Schlattmann; Isabella Heuser; Peter Neu
Journal:  J Psychiatr Res       Date:  2009-08-04       Impact factor: 4.791

9.  Attenuated cerebral vasodilatory capacity in response to hypercapnia in college-aged African Americans.

Authors:  Chansol Hurr; Kiyoung Kim; Michelle L Harrison; R Matthew Brothers
Journal:  Exp Physiol       Date:  2014-11-20       Impact factor: 2.969

10.  National Institutes of Health Toolbox Emotion Battery for English- and Spanish-speaking adults: normative data and factor-based summary scores.

Authors:  Ida Babakhanyan; Benjamin S McKenna; Kaitlin B Casaletto; Cindy J Nowinski; Robert K Heaton
Journal:  Patient Relat Outcome Meas       Date:  2018-03-15
View more
  2 in total

1.  Augmented T-cell mitochondrial reactive oxygen species in adults with major depressive disorder.

Authors:  Ann-Katrin Grotle; Ashley M Darling; Erika F Saunders; Paul J Fadel; Daniel W Trott; Jody L Greaney
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-18       Impact factor: 4.733

2.  Short-term salicylate treatment improves microvascular endothelium-dependent dilation in young adults with major depressive disorder.

Authors:  Jody L Greaney; Erika F H Saunders; Lacy M Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-04-01       Impact factor: 5.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.